文献
J-GLOBAL ID:202002217766033993
整理番号:20A2133283
脾臓チロシンキナーゼのアザベンゾイミダゾール由来阻害剤の新規シリーズの同定【JST・京大機械翻訳】
Identification of a novel series of azabenzimidazole-derived inhibitors of spleen tyrosine kinase
著者 (21件):
Kawatkar Sameer P.
(R&D Oncology, AstraZeneca, Boston, MA, United States)
,
Barlaam Bernard
(R&D Oncology, AstraZeneca, Cambridge, United Kingdom)
,
Kemmitt Paul
(R&D Oncology, AstraZeneca, Cambridge, United Kingdom)
,
Simpson Iain
(R&D Oncology, AstraZeneca, Cambridge, United Kingdom)
,
Watson David
(R&D Oncology, AstraZeneca, Cambridge, United Kingdom)
,
Wang Peng
(Pharmaron Beijing Co., Ltd., Taihe Road BDA, Beijing, 100176, PR China)
,
Lamont Scott
(R&D Oncology, AstraZeneca, Cambridge, United Kingdom)
,
Su Qibin
(R&D Oncology, AstraZeneca, Boston, MA, United States)
,
Boiko Scott
(R&D Oncology, AstraZeneca, Boston, MA, United States)
,
Ikeda Timothy
(R&D Oncology, Discovery Sciences, AstraZeneca, Cambridge, United Kingdom)
,
Patel Joe
(R&D Oncology, AstraZeneca, Boston, MA, United States)
,
Pike Andy
(R&D Oncology, AstraZeneca, Cambridge, United Kingdom)
,
Pollard Hannah
(R&D Oncology, Discovery Sciences, AstraZeneca, Cambridge, United Kingdom)
,
Read Jon
(R&D Oncology, Discovery Sciences, AstraZeneca, Cambridge, United Kingdom)
,
Sarkar Ujjal
(R&D Oncology, AstraZeneca, Boston, MA, United States)
,
Wang Haiyun
(R&D Oncology, AstraZeneca, Boston, MA, United States)
,
Wen Quanshan
(Pharmaron Beijing Co., Ltd., Taihe Road BDA, Beijing, 100176, PR China)
,
Yan Zhiyuan
(Pharmaron Beijing Co., Ltd., Taihe Road BDA, Beijing, 100176, PR China)
,
Dowling James E.
(R&D Oncology, AstraZeneca, Boston, MA, United States)
,
Dry Hannah
(R&D Oncology, AstraZeneca, Boston, MA, United States)
,
Edmondson Scott D.
(R&D Oncology, AstraZeneca, Boston, MA, United States)
資料名:
Bioorganic & Medicinal Chemistry Letters
(Bioorganic & Medicinal Chemistry Letters)
巻:
30
号:
18
ページ:
Null
発行年:
2020年
JST資料番号:
W0248A
ISSN:
0960-894X
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
オランダ (NLD)
言語:
英語 (EN)